|
PAQR3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.78809999999264E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.16639999997648E-06 |
| Normal-vs-Stage2 |
4.770000E-02 |
| Normal-vs-Stage3 |
3.882300E-02 |
| Normal-vs-Stage4 |
3.400000E-01 |
| Stage1-vs-Stage2 |
1.772780E-01 |
| Stage1-vs-Stage3 |
9.674200E-02 |
| Stage1-vs-Stage4 |
7.078100E-02 |
| Stage2-vs-Stage3 |
9.388800E-01 |
| Stage2-vs-Stage4 |
5.595600E-01 |
| Stage3-vs-Stage4 |
5.749800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.99789999999678E-05 |
| Normal-vs-AfricanAmerican |
4.864700E-03 |
| Normal-vs-Asian |
1.103240E-01 |
| Caucasian-vs-AfricanAmerican |
3.825000E-01 |
| Caucasian-vs-Asian |
7.814200E-01 |
| AfricanAmerican-vs-Asian |
9.736400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.904900000133E-07 |
| Normal-vs-Female |
5.418100E-02 |
| Male-vs-Female |
7.968600E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.176000E-04 |
| Normal-vs-Extreme_Weight |
2.85010000045105E-07 |
| Normal-vs-Obese |
2.295400E-03 |
| Normal-vs-Extreme_Obese |
1.125870E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.208000E-01 |
| Normal_Weight-vs-Obese |
6.009800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.646400E-01 |
| Extreme_Weight-vs-Obese |
5.693700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.104800E-01 |
| Obese-vs-Extreme_Obese |
5.676800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.313240E-01 |
| Normal-vs-Age(41-60Yrs) |
6.22029999999274E-05 |
| Normal-vs-Age(61-80Yrs) |
3.839400E-04 |
| Normal-vs-Age(81-100Yrs) |
2.29309999988381E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.201800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.585800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.332420E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.898200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.283000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.958300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.06869999703252E-08 |
| Normal-VS-Type2 PRCC |
1.059840E-02 |
| Normal-VS-KIRP CIMP |
6.137400E-01 |
| Normal-VS-Unclassified PRCC |
3.109700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.677800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.159500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.002230E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.457800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.769800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.074600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.51199999998131E-06 |
| Normal-vs-N1 |
4.276000E-01 |
| Normal-vs-N2 |
1.158630E-01 |
| N0-vs-N1 |
2.358100E-02 |
| N0-vs-N2 |
6.623400E-01 |
| N1-vs-N2 |
4.517000E-01 |
|
|
